Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Pharmacoepidemiology and Drug Safety|January 22, 2013
Validation of an algorithm to estimate gestational age in electronic health plan databasesQian Li, Susan E Andrade, William O Cooper, et al.Pharmacoepidemiology and Drug Safety|July 4, 2012
Validity of health plan and birth certificate data for pregnancy researchSusan E Andrade, Pamela E Scott, Robert L Davis, et al.Maternal and Child Health Journal|February 20, 2013
The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007Lyndsay A Avalos, Hong Chen, Chunmei Yang, et al.Drug Safety|April 13, 2025
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of PharmacovigilanceSalvatore Crisafulli, Andrew Bate, Jeffrey Stuart Brown, et al.Pharmacoepidemiology and Drug Safety|April 19, 2013
Methods of linking mothers and infants using health plan data for studies of pregnancy outcomesKarin E Johnson, Sarah J Beaton, Susan E Andrade, et al.Obstetrics and Gynecology|December 25, 2012
Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007Jean M Lawrence, Susan E Andrade, Lyndsay A Avalos, et al.Maternal and Child Health Journal|October 18, 2011
Medication Exposure in Pregnancy Risk Evaluation ProgramSusan E Andrade, Robert L Davis, T Craig Cheetham, et al.Clinical and Translational Science|June 3, 2021
Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the ratLin Xu, Ashok Krishna, Sharron Stewart, et al.Archives of Women'S Mental Health|February 8, 2013
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveriesSengwee Toh, Qian Li, T Craig Cheetham, et al.Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.Pageof 8